Literature DB >> 31132220

MMP-9-positive neutrophils are essential for establishing profibrotic microenvironment in the obstructed kidney of UUO mice.

Haidong Wang1,2, Min Gao1, Jiangbo Li1, Jian Sun1,3, Ran Wu1, Deping Han1, Jianmei Tan1, Juan Wang4, Bin Wang5, Liping Zhang2,6, Yanjun Dong1.   

Abstract

AIM: Matrix metalloproteinase-9 (MMP9) plays a profibrotic role in renal fibrosis. Neutrophils produce MMP9 in many pathologic models. However, the effect of neutrophil on the progression of renal fibrosis and the relationship of MMP9 to the infiltration of neutrophils into the kidney remain unknown.
METHODS: The surgery of unilateral ureter obstruction (UUO) was performed in male C57BL/6 mice. Kidneys were collected for analyses on days 0, 1, 3, 5 or 7 following surgery. The inflammatory cells were analysed by flow cytometry. The mRNA and protein levels of renal fibrosis factor and inflammatory factor were measured by qRT-PCR, immumofluorescence and western blot analysis.
RESULTS: In a mouse kidney model of UUO, neutrophil infiltration significantly increased and neutrophil accumulation reached the highest level at 5 days after the injury. In the obstructed kidney, depleting neutrophils decreased the expression of inflammatory factors, inhibited the accumulation of macrophages including type 2 macrophages and suppressed renal fibrosis. Almost all neutrophils produced MMP9 at the early stage of kidney obstruction. MMP9 attracted neutrophils and inflammatory cells because inhibiting MMP9 suppressed the infiltration of neutrophils and other inflammatory cells and reduced renal fibrosis, regardless of using MMP9 neutralizing antibody or MMP9 inhibitor or different intervening periods of days (0-6, 0-3 or 3-6 were applied after kidney obstruction).
CONCLUSION: MMP9 promotes neutrophil infiltration by increasing the inflammatory level, macrophage accumulation and renal fibrosis in the obstructed kidney. Inhibiting MMP9 or depleting neutrophils in the early stage of acute kidney injury can relieve the progression of kidney fibrosis.
© 2019 Scandinavian Physiological Society. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  fibrosis; inflammation; kidney; macrophage; neutrophil

Year:  2019        PMID: 31132220     DOI: 10.1111/apha.13317

Source DB:  PubMed          Journal:  Acta Physiol (Oxf)        ISSN: 1748-1708            Impact factor:   6.311


  12 in total

1.  Mechanisms of Cardiorenal Protection With SGLT2 Inhibitors in Patients With T2DM Based on Network Pharmacology.

Authors:  Anzhu Wang; Zhendong Li; Sun Zhuo; Feng Gao; Hongwei Zhang; Zhibo Zhang; Gaocan Ren; Xiaochang Ma
Journal:  Front Cardiovasc Med       Date:  2022-05-23

2.  Renoprotection of Microcystin-RR in Unilateral Ureteral Obstruction-Induced Renal Fibrosis: Targeting the PKM2-HIF-1α Pathway.

Authors:  Yan Ren; Jie Wang; Wenwen Guo; Jingwen Chen; Xin Wu; Shubo Gu; Lizhi Xu; Zhiwei Wu; Yaping Wang
Journal:  Front Pharmacol       Date:  2022-06-09       Impact factor: 5.988

3.  15-Lipoxygenase worsens renal fibrosis, inflammation, and metabolism in a murine model of ureteral obstruction.

Authors:  John R Montford; Colin Bauer; Jeremy Rahkola; Julie A Reisz; Deanna Floyd; Katharina Hopp; Danielle E Soranno; Jelena Klawitter; Mary C M Weiser-Evans; Raphael Nemenoff; Sarah Faubel; Seth B Furgeson
Journal:  Am J Physiol Renal Physiol       Date:  2021-12-06

4.  Naringin attenuates renal interstitial fibrosis by regulating the TGF-β/Smad signaling pathway and inflammation.

Authors:  Ruichen Wang; Gaolei Wu; Tiantian Dai; Yitian Lang; Zhongchao Chi; Shilei Yang; Deshi Dong
Journal:  Exp Ther Med       Date:  2020-11-23       Impact factor: 2.447

5.  Expression and Potential Role of MMP-9 in Intrauterine Adhesion.

Authors:  Congqing Li; Wenyan Wang; Shiying Sun; Youjiang Xu; Ziang Fang; Lin Cong
Journal:  Mediators Inflamm       Date:  2021-01-29       Impact factor: 4.711

Review 6.  Advances in the Progression and Prognosis Biomarkers of Chronic Kidney Disease.

Authors:  Zhonghong Yan; Guanran Wang; Xingyang Shi
Journal:  Front Pharmacol       Date:  2021-12-21       Impact factor: 5.810

7.  1,4-Disubstituted 1H-1,2,3-Triazoles for Renal Diseases: Studies of Viability, Anti-Inflammatory, and Antioxidant Activities.

Authors:  Ching-Yi Cheng; Ashanul Haque; Ming-Fa Hsieh; Syed Imran Hassan; Md Serajul Haque Faizi; Necmi Dege; Muhammad S Khan
Journal:  Int J Mol Sci       Date:  2020-05-28       Impact factor: 5.923

8.  Prediction of severity and subtype of fibrosing disease using model informed by inflammation and extracellular matrix gene index.

Authors:  Amin M Cheikhi; Zariel I Johnson; Dana R Julian; Sarah Wheeler; Carol Feghali-Bostwick; Yvette P Conley; James Lyons-Weiler; Cecelia C Yates
Journal:  PLoS One       Date:  2020-10-23       Impact factor: 3.240

9.  Myeloid-Derived Suppressor Cells Alleviate Renal Fibrosis Progression via Regulation of CCL5-CCR5 Axis.

Authors:  Yue Qiu; Yirui Cao; Guowei Tu; Jiawei Li; Ying Su; Fang Fang; Xuepeng Zhang; Jing Cang; Ruiming Rong; Zhe Luo
Journal:  Front Immunol       Date:  2021-09-10       Impact factor: 7.561

10.  Mobile Colistin Resistance Enzyme MCR-3 Facilitates Bacterial Evasion of Host Phagocytosis.

Authors:  Wenjuan Yin; Zhuoren Ling; Yanjun Dong; Lu Qiao; Yingbo Shen; Zhihai Liu; Yifan Wu; Wan Li; Rong Zhang; Timothy R Walsh; Chongshan Dai; Juan Li; Hui Yang; Dejun Liu; Yang Wang; George Fu Gao; Jianzhong Shen
Journal:  Adv Sci (Weinh)       Date:  2021-07-29       Impact factor: 16.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.